Impact of dynamically-modified management on patients with type 2 diabetes mellitus in the context of diagnosis-related group system
10.3760/cma.j.cn115822-20231028-00050
- VernacularTitle:DRG背景下采用动态诊疗方案对2型糖尿病患者的影响
- Author:
Jie ZHENG
1
;
Shiwei LIU
;
Qianqian YANG
;
Ruixue DUAN
;
Wanrong DOU
;
Chenxia ZHANG
Author Information
1. 山西白求恩医院 山西医学科学院 山西同济医院 山西医科大学第三医院内分泌科，太原 030032
- Keywords:
Type 2 diabetes;
Insulin;
Blood glucose monitoring
- From:
Chinese Journal of Clinical Nutrition
2023;31(6):330-335
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze and compare the effects of conventional treatment and the dynamic 3C therapy, continuous glucose monitoring system, and on outcomes, length of hospital stay and medical costs in patients with type 2 diabetes mellitus.Methods:A total of 122 type 2 diabetes mellitus patients who visited the Department of Endocrinology of Shanxi Baiqiu'en Hospital between June 2022 and December 2022 were selected and randomized at 1:1 into the control group and the experimental group using the randomized numerical table method. The t-test and non-parametric test were used as appropriate to compare the glycemic control, length of hospital stay and medical costs of the two groups.Results:Before treatment, there was no significant difference in the indicators for blood glucose levels and fluctuations between the two groups ( P>0.05). After treatment, the glycosylated hemoglobin, fasting plasma glucose, and 2-hour postprandial blood glucose decreased in both groups. Moreover, the glycosylated hemoglobin, fasting plasma glucose, and 2-hour postprandial blood glucose showed more significant decreases in the experimental group compared with the control group after treatment. The glycemic variability indicators, including the time out of range, standard deviation of blood glucose, and the largest amplitude of glycemic excursion, decreased after treatment in both groups. The time in range increased after treatment. After treatment, the standard deviation of blood glucose and the largest amplitude of glycemic excursion in the experimental group were lower than those in the control group, and the length of hospital stay in the experimental group was shortened (all P<0.05). Conclusion:3C therapy contributes to better glycemic control and shorter hospital stay in patients with type 2 diabetes mellitus.
